arrow
S

Simone Giuliano

azienda sanitaria universitaria friuli centrale
H指数:13
被引数:604

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical, Microbiological and Genomic Characterization of OXA-48-Producing Klebsiella pneumoniae ST395 Circulating in a Secondary-Care Hospital in North-Eastern Italy, 2024–2025

2024–2025年在意大利东北部一家二级医院中流行的产OXA-48型肺炎克雷伯菌ST395的临床、微生物学和基因组特征

2026-09-150
OA
Does acute pyelonephritis skew outcomes in registrational trials of novel antibiotics for complicated urinary tract infections? A systematic review and meta-analysis

急性肾盂肾炎是否影响复杂尿路感染新型抗生素注册试验的结局?一项系统评价和荟萃分析

2026-08-270
OAAI
Precision redosing of oritavancin: A population pharmacokinetic framework to optimize long-term therapy for complex gram-positive infections

奥利万克星精确再给药:用于优化复杂革兰阳性菌感染长期治疗的人群药代动力学框架

2026-08-010
PRE
Oritavancin as consolidation or suppressive therapy in infective endocarditis and device-related infections: real-world experience with therapeutic drug monitoring

奥利万克霉素作为感染性心内膜炎和器械相关感染的巩固或抑制疗法:治疗药物监测的真实世界经验

2026-07-240
OAAI
Emergence of dalbavancin non-susceptible methicillin-resistant Staphylococcus epidermidis (MRSE) in a patient treated with dalbavancin prolonged therapy: Case report, therapeutic drug monitoring and genomic characterization

达巴万星非敏感性耐甲氧西林表皮葡萄球菌(MRSE)在达巴万星长期治疗患者中的出现:病例报告、治疗药物监测及基因组特征

2026-06-050
PRE
Outpatient Parenteral Antimicrobial Therapy (OPAT) in Italy: A Scoping Review

意大利门诊静脉抗菌治疗(OPAT):一项范围综述

2026-02-090
OAAI
OXA-carbapenemases and mutations within PBPs in ST2 carbapenem-resistant A. baumannii: Evaluating the efficacy of cefiderocol and ampicillin-sulbactam combination therapy

OXA-碳青霉烯酶和ST2碳青霉烯耐药鲍曼不动杆菌中青霉素结合蛋白(PBPs)的突变:评估头孢地尼科尔与氨苄西林-舒巴坦联合疗法的疗效

2025-06-270
OAAI
Escherichia coli producing AmpC DHA-1 bacteraemia in neutropenic leukemic patient: continuous infusion ceftazidime/avibactam as a carbapenem sparing regimen

携带AmpC DHA-1的埃希氏菌属大肠杆菌在粒细胞减少的白血病患者中引起的菌血症:连续输注头孢他啶/阿维巴坦作为碳青霉烯类节约方案

2025-06-010
PRE
Coagulative Biomarkers Differently Predict Clinical Outcomes in Invasive Infections Caused by Neisseria Meningitidis and Streptococcus Pneumoniae

凝固生物标志物对由Neisseria meningitidis和Streptococcus pneumoniae引起的侵袭性感染的临床结局具有不同的预测作用

2025-03-012
OAAI
Current role of ceftobiprole in the treatment of hospital-acquired and community-acquired pneumonia: expert opinion based on literature and real-life experiences

头孢比普乐在医院获得性和社区获得性肺炎治疗中的当前作用: 基于文献和现实生活经验的专家意见

2025-02-050
PRE